Literature DB >> 16882683

A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis.

François Chappuis1, Suman Rijal, Alonso Soto, Joris Menten, Marleen Boelaert.   

Abstract

OBJECTIVE: To compare the performance of the direct agglutination test and rK39 dipstick for the diagnosis of visceral leishmaniasis. DATA SOURCES: Medline, citation tracking, January 1986 to December 2004. Selection criteria Original studies evaluating the direct agglutination test or the rK39 dipstick with clinical visceral leishmaniasis as target condition; adequate reference classification; and absolute numbers of true positive, true negative, false positive, and false negative observations available or derivable from the data presented.
RESULTS: 30 studies evaluating the direct agglutination test and 13 studies evaluating the rK39 dipstick met the inclusion criteria. The combined sensitivity estimates of the direct agglutination test and the rK39 dipstick were 94.8% (95% confidence interval 92.7% to 96.4%) and 93.9% (87.7% to 97.1%), respectively. Sensitivity seemed higher and more homogenous in the studies carried out in South Asia. Specificity estimates were influenced by the type of controls. In phase III studies carried out on patients with clinically suspected disease, the estimated specificity of the direct agglutination test was 85.9% (72.3% to 93.4%) and of the rK39 dipstick was 90.6% (66.8% to 97.9%).
CONCLUSION: The diagnostic performance of the direct agglutination test and the rK39 dipstick for visceral leishmaniasis is good to excellent and seem comparable.

Entities:  

Mesh:

Year:  2006        PMID: 16882683      PMCID: PMC1592383          DOI: 10.1136/bmj.38917.503056.7C

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  15 in total

1.  Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.

Authors:  M Boelaert; L Lynen; P Desjeux; P Van der Stuyft
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

2.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

Review 3.  Diagnostics for the developing world.

Authors:  David Mabey; Rosanna W Peeling; Andrew Ustianowski; Mark D Perkins
Journal:  Nat Rev Microbiol       Date:  2004-03       Impact factor: 60.633

4.  Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda.

Authors:  François Chappuis; Yolanda Mueller; Alexandre Nguimfack; John Bosco Rwakimari; Sophie Couffignal; Marleen Boelaert; Philippe Cavailler; Louis Loutan; Patrice Piola
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 5.  Leishmaniasis. Public health aspects and control.

Authors:  P Desjeux
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

6.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

7.  rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.

Authors:  E E Zijlstra; N S Daifalla; P A Kager; E A Khalil; A M El-Hassan; S G Reed; H W Ghalib
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  A direct agglutination test for leishmaniasis.

Authors:  D S Allain; I G Kagan
Journal:  Am J Trop Med Hyg       Date:  1975-03       Impact factor: 2.345

9.  rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis.

Authors:  R Badaró; D Benson; M C Eulálio; M Freire; S Cunha; E M Netto; D Pedral-Sampaio; C Madureira; J M Burns; R L Houghton; J R David; S G Reed
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

10.  Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

Authors:  S Singh; A Gilman-Sachs; K P Chang; S G Reed
Journal:  J Parasitol       Date:  1995-12       Impact factor: 1.276

View more
  97 in total

1.  Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.

Authors:  Geraldo G S Oliveira; Franklin B Magalhães; Márcia C A Teixeira; Andrea M Pereira; Cristiane G M Pinheiro; Lenita R Santos; Marília B Nascimento; Cheila N G Bedor; Alessandra L Albuquerque; Washington L C dos-Santos; Yara M Gomes; Edson D Moreira; Maria E F Brito; Lain C Pontes de Carvalho; Osvaldo P de Melo Neto
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.

Authors:  Siddhivinayak Hirve; Shri Prakash Singh; Narendra Kumar; Megha Raj Banjara; Pradeep Das; Shyam Sundar; Suman Rijal; Anand Joshi; Axel Kroeger; Beena Varghese; Chandreshwar Prasad Thakur; M Mamun Huda; Dinesh Mondal
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Rapid detection of Trypanosoma cruzi in human serum by use of an immunochromatographic dipstick test.

Authors:  Richard Reithinger; Mario J Grijalva; Rosa F Chiriboga; Belkisyolé Alarcón de Noya; Jaime R Torres; Norma Pavia-Ruz; Pablo Manrique-Saide; Marta V Cardinal; Ricardo E Gürtler
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

4.  Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Authors:  Carmen Cañavate; Merce Herrero; Javier Nieto; Israel Cruz; Carmen Chicharro; Pilar Aparicio; Abate Mulugeta; Daniel Argaw; Anna J Blackstock; Jorge Alvar; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 5.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

6.  Serological tests for visceral leishmaniasis.

Authors:  Diana N J Lockwood; Shyam Sundar
Journal:  BMJ       Date:  2006-10-07

Review 7.  Molecular diagnosis of leishmaniasis: current status and future applications.

Authors:  Richard Reithinger; Jean-Claude Dujardin
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

8.  Use of a newly developed beta-mercaptoethanol enzyme-linked immunosorbent assay to diagnose visceral leishmaniasis in patients in eastern Sudan.

Authors:  Durria Mansour; Elfadil M Abass; Mohamed El Mutasim; Abdelhafeiz Mahamoud; Abdallah El Harith
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

9.  Comparison of microscopic examination, rK39, and PCR for visceral leishmaniasis diagnosis in Turkey.

Authors:  Dilek Ozerdem; Fadime Eroglu; Ahmet Genc; Mehtap Demirkazik; Ismail Soner Koltas
Journal:  Parasitol Res       Date:  2009-10-27       Impact factor: 2.289

10.  ELISA and western blotting for the detection of Hsp70 and Hsp83 antigens of Leishmania donovani.

Authors:  Jaspreet Kaur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.